NanoViricides, Inc. (NNVC)

NYSE MKT - NYSE MKT Real Time Price. Currency in USD
1.50-0.04 (-2.60%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close1.54
Bid1.50 x 100
Ask1.51 x 200
Day's Range1.47 - 1.55
52wk Range0.96 - 3.44
1y Target EstN/A
Market Cap86.96M
P/E Ratio (ttm)-8.24
Avg Vol (3m)63,160
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswire13 days ago

    NanoViricides Has Filed Annual Report, Says Company Has Sufficient Cash To Advance Into Clinical Trials

    SHELTON, Conn., Oct. 11, 2016 /PRNewswire/ -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), reports that it has filed its financial year end annual report (Form 10-K) with the Securities and Exchange Commission (SEC) on Friday, September 16, 2016 in a timely manner. NanoViricides, Inc. is a global leader in the application of nanomedicine technologies to the complex issues of viral diseases. The nanoviricide® technology enables direct attacks at multiple points on a virus particle.

  • PR Newswirelast month

    NanoViricides to Present at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City Today

    SHELTON, Conn., Sept. 13, 2016 /PRNewswire/ -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), a global leader in nanomedicines that is developing biomimetic anti-viral drugs announced that it will be featured as a presenting company today at the 18th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held on September 11-13, 2016, at Lotte New York Palace Hotel in New York City. Eugene Seymour, MD, MPH, CEO of NanoViricides, will provide an overview of the Company's business and will be available to participate in one-on-one meetings with investors who are registered to attend the conference. Dr Seymour's presentation is scheduled for 10am on Tuesday, September 13th, in the Holmes-I conference room. If you are an institutional investor, and would like to attend the Company's presentation, please click the link to register for the Rodman & Renshaw conference.

  • PR Newswire2 months ago

    NanoViricides Reports on Senator Murphy's Visit to the Company's Shelton Campus

    SHELTON, Conn., Aug. 25, 2016 /PRNewswire/ -- NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), a global leader in nanomedicines that is developing biomimetic anti-viral drugs reports that Honorable U.S. Senator Chris Murphy visited the Company's new campus in Shelton, CT, on Wednesday, August 24th, 2016. "NanoViricides is exactly the type of innovative company that is driving job creation throughout greater New Haven and the Naugatuck Valley," said Senator Murphy, adding, "I was incredibly impressed by the company and enjoyed hearing from employees during my town hall about how I can best help them and other bioscience entrepreneurs cut through red tape.